312 related articles for article (PubMed ID: 9440958)
1. [Is there still a role for tocolysis in treatment of threatened premature labor?].
Spätling L
Z Geburtshilfe Neonatol; 1997; 201(5):182. PubMed ID: 9440958
[No Abstract] [Full Text] [Related]
2. [Tocolysis].
Spätling L
Z Geburtshilfe Neonatol; 1997; 201 Suppl 1():25-9. PubMed ID: 9410526
[TBL] [Abstract][Full Text] [Related]
3. [Good sense and nonsense in tocolysis].
Husslein P; Reisenberger K; Leitich C
Zentralbl Gynakol; 1995; 117(6):300-3. PubMed ID: 7645357
[TBL] [Abstract][Full Text] [Related]
4. [In which pregnancy trimester is therapy with beta-mimetics of value? Beta receptor density in the course of pregnancy?].
Spätling L
Gynakologe; 1992 Jun; 25(3):201. PubMed ID: 1354629
[No Abstract] [Full Text] [Related]
5. [Beta-mimetic drug therapy: pro and contra].
Baumgarten K
Gynakol Geburtshilfliche Rundsch; 1993; 33 Suppl 1():136-8. PubMed ID: 7906976
[No Abstract] [Full Text] [Related]
6. [Usefulness of beta mimetic treatment in threatened premature labor].
Audra P; Mellier G; Keita N; Claris O; Zavaglia AM
Rev Fr Gynecol Obstet; 1992; 87(7-9):385-8. PubMed ID: 1359626
[No Abstract] [Full Text] [Related]
7. [Medical tocolysis in threatening premature labor: what is safe in therapy?].
Grospietsch G
Gynakologe; 1991 Aug; 24(4):188-97. PubMed ID: 1682223
[No Abstract] [Full Text] [Related]
8. Arg16 homozygosity of the beta2-adrenergic receptor improves the outcome after beta2-agonist tocolysis for preterm labor.
Landau R; Morales MA; Antonarakis SE; Blouin JL; Smiley RM
Clin Pharmacol Ther; 2005 Dec; 78(6):656-63. PubMed ID: 16338281
[TBL] [Abstract][Full Text] [Related]
9. [Tocolytic therapy in breech presentation and threatened premature labor].
Roemer VM
Z Geburtshilfe Neonatol; 1997; 201(3):201. PubMed ID: 9303784
[No Abstract] [Full Text] [Related]
10. [What treatment in threatened premature labor?].
Thoulon JM
Rev Fr Gynecol Obstet; 1992; 87(7-9):388, 391. PubMed ID: 1359627
[No Abstract] [Full Text] [Related]
11. [Fetal advantages and benefits of the treatment of threatened premature labor by beta mimetics].
Bourgeois J
Rev Fr Gynecol Obstet; 1992; 87(7-9):391-2. PubMed ID: 1359628
[No Abstract] [Full Text] [Related]
12. [Fetal arrhythmia--a complication of betamimetic tocolysis?].
Zalányi S; Kovács L; Kertész E
Orv Hetil; 1980 Oct; 121(43):2652-4. PubMed ID: 6111062
[No Abstract] [Full Text] [Related]
13. [Treatment of threatened premature labor by beta mimetic drugs. Experience at the Hôtel-Dieu].
Molnar J; Carak M; Thoulon JM
Rev Fr Gynecol Obstet; 1992; 87(7-9):381-3. PubMed ID: 1359625
[No Abstract] [Full Text] [Related]
14. [Aspects of the therapy of threatened premature labor].
Unbehaun V; Conradt A; Meiswinkel E
Med Welt; 1972 Dec; 23(51):1920-2. PubMed ID: 4145263
[No Abstract] [Full Text] [Related]
15. [Magnesium and tocolysis].
Weidinger H
Gynakol Geburtshilfliche Rundsch; 1993; 33 Suppl 1():139-42. PubMed ID: 7906977
[No Abstract] [Full Text] [Related]
16. [Adrenergic beta receptor agonists in threatened preterm labor].
Rasmussen OB
Ugeskr Laeger; 1993 Aug; 155(32):2480-1. PubMed ID: 8102825
[No Abstract] [Full Text] [Related]
17. [Tocolysis, use of beta-sympatomimetics for threatening preterm delivery: a critical review].
Rozenberg P
J Gynecol Obstet Biol Reprod (Paris); 2001 May; 30(3):221-30. PubMed ID: 11397997
[TBL] [Abstract][Full Text] [Related]
18. [Adrenergic beta-2 receptors and cyclic AMP in lymphocytes and their relationship to uterine contractility].
von Mandach U
Z Geburtshilfe Perinatol; 1994; 198(5-6):201-3. PubMed ID: 7717008
[TBL] [Abstract][Full Text] [Related]
19. [Premature labor--central problem of modern obstetrics].
Strobel E
Fortschr Med; 1997 Jul; 115(19):28-31. PubMed ID: 9333578
[No Abstract] [Full Text] [Related]
20. [Bolus tocolysis in theory and practice].
Schneider H
Geburtshilfe Frauenheilkd; 1992 Oct; 52(10):640-1. PubMed ID: 1363469
[No Abstract] [Full Text] [Related]
[Next] [New Search]
